Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1992 Apr;68(798):263–267. doi: 10.1136/pgmj.68.798.263

Treatment of Raynaud's phenomenon with triiodothyronine corrects co-existent autonomic dysfunction: preliminary findings.

R F Gledhill 1, P H Dessein 1, C A Van der Merwe 1
PMCID: PMC2399264  PMID: 1409189

Abstract

Cardiovascular autonomic function was assessed in 9 subjects with Raynaud's phenomenon. The underlying diseases were systemic lupus erythematosus (n = 5), systemic sclerosis (n = 3) and rheumatoid arthritis (n = 1). Five standard non-invasive tests, 3 of heart rate and 2 of blood pressure, were employed. Compared with age and sex matched controls (n = 25), the number of values abnormal was 24 of 45 (53%) overall and between one and 4 (median, 2) individually. Significant differences were present for 3 tests, two of heart rate and one of blood pressure. The subjects were given triiodothyronine, 60 to 80 micrograms per day, for vasospastic attacks. Autonomic function was reassessed between weeks 4 and 9 (9 subjects) and between weeks 12 and 18 (8 subjects) after introduction of triiodothyronine. Test results showed a considerable improvement. At the second reassessment, the number of values abnormal was now 5 of 40 (12.5%) overall and nil (n = 4) or one (n = 4) individually. Significant differences remained for one heart rate test only. Adverse side effects to triiodothyronine occurred in a single subject and were readily controlled. Evidence of somatic neuropathy was present electrophysiologically in all 9 subjects and clinically in 8. Triiodothyronine may have corrected autonomic dysfunction by increasing blood flow to ischaemic peripheral nerves or by acting on the autonomic system more directly. Further study of triiodothyronine in autonomic insufficiency appears merited.

Full text

PDF
263

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atterwill C. K., Bunn S. J., Atkinson D. J., Smith S. L., Heal D. J. Effects of thyroid status on presynaptic alpha 2-adrenoceptor function and beta-adrenoceptor binding in the rat brain. J Neural Transm. 1984;59(1):43–55. doi: 10.1007/BF01249877. [DOI] [PubMed] [Google Scholar]
  2. BARKER S. B., KLITGAARD H. M. Metabolism of tissues excised from thyroxine-injected rats. Am J Physiol. 1952 Jul;170(1):81–86. doi: 10.1152/ajplegacy.1952.170.1.81. [DOI] [PubMed] [Google Scholar]
  3. Bilezikian J. P., Loeb J. N. The influence of hyperthyroidism and hypothyroidism on alpha- and beta-adrenergic receptor systems and adrenergic responsiveness. Endocr Rev. 1983 Fall;4(4):378–388. doi: 10.1210/edrv-4-4-378. [DOI] [PubMed] [Google Scholar]
  4. Dessein P. H., Gledhill R. F. More on autonomic neuropathy in systemic sclerosis. Ann Rheum Dis. 1988 Mar;47(3):261–263. doi: 10.1136/ard.47.3.261-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dessein P. H., Gledhill R. F. Treatment of Raynaud's phenomenon with large doses of triiodothyronine: a pilot study. Ann Rheum Dis. 1987 Dec;46(12):944–945. doi: 10.1136/ard.46.12.944. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dessein P. H., Morrison R. C., Lamparelli R. D., van der Merwe C. A. Triiodothyronine treatment for Raynaud's phenomenon: a controlled trial. J Rheumatol. 1990 Aug;17(8):1025–1028. [PubMed] [Google Scholar]
  7. Edmonds M. E., Jones T. C., Saunders W. A., Sturrock R. D. Autonomic neuropathy in rheumatoid arthritis. Br Med J. 1979 Jul 21;2(6183):173–175. doi: 10.1136/bmj.2.6183.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ewing D. J., Clarke B. F. Autonomic neuropathy: its diagnosis and prognosis. Clin Endocrinol Metab. 1986 Nov;15(4):855–888. doi: 10.1016/s0300-595x(86)80078-0. [DOI] [PubMed] [Google Scholar]
  9. Gledhill R. F., Dessein P. H. Autonomic neuropathy in systemic lupus erythematosus. J Neurol Neurosurg Psychiatry. 1988 Sep;51(9):1238–1240. doi: 10.1136/jnnp.51.9.1238-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Klimiuk P. S., Taylor L., Baker R. D., Jayson M. I. Autonomic neuropathy in systemic sclerosis. Ann Rheum Dis. 1988 Jul;47(7):542–545. doi: 10.1136/ard.47.7.542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Leden I., Eriksson A., Lilja B., Sturfelt G., Sundkvist G. Autonomic nerve function in rheumatoid arthritis of varying severity. Scand J Rheumatol. 1983;12(2):166–170. doi: 10.3109/03009748309102905. [DOI] [PubMed] [Google Scholar]
  12. McCombe P. A., McLeod J. G., Pollard J. D., Guo Y. P., Ingall T. J. Peripheral sensorimotor and autonomic neuropathy associated with systemic lupus erythematosus. Clinical, pathological and immunological features. Brain. 1987 Apr;110(Pt 2):533–549. doi: 10.1093/brain/110.2.533. [DOI] [PubMed] [Google Scholar]
  13. McLeod J. G., Tuck R. R. Disorders of the autonomic nervous system: Part 1. Pathophysiology and clinical features. Ann Neurol. 1987 May;21(5):419–430. doi: 10.1002/ana.410210502. [DOI] [PubMed] [Google Scholar]
  14. McLeod J. G., Tuck R. R. Disorders of the autonomic nervous system: Part 2. Investigation and treatment. Ann Neurol. 1987 Jun;21(6):519–529. doi: 10.1002/ana.410210602. [DOI] [PubMed] [Google Scholar]
  15. Olsen N., Petring O. U., Rossing N. Exaggerated postural vasoconstrictor reflex in Raynaud's phenomenon. Br Med J (Clin Res Ed) 1987 May 9;294(6581):1186–1188. doi: 10.1136/bmj.294.6581.1186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. PEACOCK J. H. The treatment of primary Raynaud's disease of the upper limb. Lancet. 1960 Jul 9;2(7141):65–69. doi: 10.1016/s0140-6736(60)91214-9. [DOI] [PubMed] [Google Scholar]
  17. SMITH D. J. Immediate sensitization of isolated swine arteries and their vasa vasorum to epinephrine, acetylcholine and histamine by thyroxine. Am J Physiol. 1954 Apr;177(1):7–12. doi: 10.1152/ajplegacy.1954.177.1.7. [DOI] [PubMed] [Google Scholar]
  18. Singhal R. L., Rastogi R. B., Hrdina P. D. Brain biogenic amines and altered thyroid function. Life Sci. 1975 Dec 1;17(11):1617–1626. doi: 10.1016/0024-3205(75)90106-x. [DOI] [PubMed] [Google Scholar]
  19. Sonnex C., Paice E., White A. G. Autonomic neuropathy in systemic sclerosis: a case report and evaluation of six patients. Ann Rheum Dis. 1986 Nov;45(11):957–960. doi: 10.1136/ard.45.11.957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Sterling K. Thyroid hormone action at the cell level (second of two parts). N Engl J Med. 1979 Jan 25;300(4):173–177. doi: 10.1056/NEJM197901253000405. [DOI] [PubMed] [Google Scholar]
  21. Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. doi: 10.1002/art.1780251101. [DOI] [PubMed] [Google Scholar]
  22. van Zwieten P. A., Timmermans P. B. Cardiovascular alpha 2-receptors. J Mol Cell Cardiol. 1983 Nov;15(11):717–733. doi: 10.1016/0022-2828(83)90332-2. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES